Antibiotic modification of native grafts: Improving upon nature's scaffolds

Tissue Engineering - Part A

Volumn 16, Issue 6, 2010, Pages 2041-2049

  Ketonis, Constantinos ^a   Adams, Christopher S ^a   Barr, Stephanie ^a   Aiyer, Amiethab ^a   Shapiro, Irving M ^a   Parvizi, Javad ^a,b   Hickok, Noreen J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b ROTHMAN INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; ANTIBIOTICS; BACTERIOLOGY; SYNTHESIS (CHEMICAL);

ANTIBACTERIAL PROPERTIES; BACTERIAL BIOFILM; BACTERIAL COLONIZATION; BONE ALLOGRAFTS; CHEMICAL SYNTHESIS; IMMUNOHISTOCHEMISTRY; PRIMARY AMINES; STAPHYLOCOCCUS AUREUS; VANCOMYCIN;

BONE;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS AUREUS;

AMINE; ANTIINFECTIVE AGENT; TISSUE SCAFFOLD; VANCOMYCIN;

ALLOTRANSPLANTATION; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; HUMAN; IMMUNOHISTOCHEMISTRY; METHODOLOGY; STAPHYLOCOCCUS AUREUS;

AMINES; ANTI-BACTERIAL AGENTS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, CONFOCAL; SPECTROPHOTOMETRY, ATOMIC; STAPHYLOCOCCUS AUREUS; TISSUE SCAFFOLDS; TRANSPLANTATION, HOMOLOGOUS; VANCOMYCIN;

EID: 77953013072     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2009.0610     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. www.cdc.gov. 2010.
2. Enneking, W.F., Mindell, E.R., Burchardt, H., and Tomford, W. Allograft safety and ethical considerations: editorial comment. Clin Orthop Rel Res 435, 2, 2005.
3. Lewandrowski, K., Gresser, J., Wise, D., and Trantol, D. Bioresorbable bone graft substitutes of different osteo-conductivities: a histologic evaluation of osteointegration of poly(propylene glycol-co-fumaric acid)-based cement implants in rats. Biomaterials 21, 757, 2000.
4. Boyce, T., Edwards, J., and Scarborough, N. Allograft bone. The influence of processing on safety and performance. Orthop Clin N Am 30, 571, 1999.
5. Souli, M., and Giamarellou, H. Effects of slime produced by clinical isolates of coagulase-negative staphylococci on activities of various antimicrobial agents. Antimicrob Agents Chemother 42, 939, 1998.
6. Buttaro, M., Comba, F., and Piccaluga, F. Vancomycin-sup-plemented cancellous bone allografts in hip revision surgery. Clin Orthop Relat Res 461, 74, 2007.
7. Keidar, Z., Engel, A., Hoffman, A., Israel, O., and Nitecki, S. Prosthetic vascular graft infection: The role of 18F-FDG PET=CT. J Nucl Med 48, 1230, 2007.
8. Chang, J., Calligaro, K., Ryan, S., Runyan, D., Dougherty, M., and Stern, J. Risk factors associated with infection of lower extremity revascularization: analysis of 365 procedures performed at a teaching hospital. Ann Vasc Surg 17, 91, 2003.
9. Costerton, J.W., Stewart, P.S., and Greenberg, E.P. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318, 1999.
10. Witso, E., Persen, L., Benum, P., and Bergh, K. Cortical allograft as a vehicle for antibiotic delivery. Acta Orthop 76, 481, 2005.
11. Lord, C., Gebhardt, M., Tomford, W., and Mankin, H. Infection in bone allografts. Incidence, nature, and treatment. J Bone Joint Surg Am 70, 369, 1988.
12. Tomford, W., Thongphasuk, J., Mankin, H., and Ferraro, M. Frozen musculoskeletal allografts. A study of the clinical incidence and causes of infection associated with their use. J Bone Joint Surg Am 72, 1137, 1990.
13. Aro, H., and Aho, A. Clinical use of bone allografts. Ann Med 25, 403, 1993.
14. Gross, A., Hutchison, C., Alexeeff, M., Mahomed, N., Leitch, K., and Morsi, E. Proximal femoral allografts for reconstruction of bone stock in revision arthroplasty of the hip. Clin Orthop Relat Res 319, 151, 1995.
15. Bauer, T. Bone graft substitutes. Skelet Radiol 36, 1105, 2007.
16. Beardmore, A. Effectiveness of local antibiotic delivery with an osteoinductive and osteoconductive bone-graft substitute. J Bone Joint Surg Br 87, 107, 2005.
17. Winkler, H., Kaudela, K., Stoiber, A., and Menschik, F. Bone grafts impregnated with antibiotics as a tool for treating infected implants in orthopedic surgery\one stage revision results. Cell Tissue Bank 7, 319, 2006.
18. Jose, B., Antoci, V., Jr., Zeiger, A.R., Wickstrom, E., and Hickok, N.J. Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus. Chem Biol 12, 1041, 2005.
19. Edupuganti, O.P., Antoci, V., Jr., King, S.B., Jose, B., Adams, C.S., Parvizi, J., Shapiro, I.M., Zeiger, A.R., Hickok, N.J., and Wickstrom, E. Covalent bonding of vancomycin to Ti6Al4V alloy pins provides long-term inhibition of Staphylococcus aureus colonization. Bioorg Med Chem Lett 17, 2692, 2007.
20. Antoci, V., Jr., Adams, C.S., Parvizi, J., Davidson, H.M., Composto, R.J., Freeman, T.A., Wickstrom, E., Ducheyne, P., Jungkind, D., Shapiro, I.M., and Hickok, N.J. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials 29, 4684, 2008.
21. Antoci, V., Jr., King, S.B., Jose, B., Parvizi, J., Zeiger, A.R., Wickstrom, E., Freeman, T.A., Composto, R.J., Ducheyne, P., Shapiro, I.M., Hickok, N.J., and Adams, C.S. Vancomycin covalently bonded to titanium alloy prevents bacterial colonization. J Orthop Res 25, 858, 2007.
22. Antoci, V., Jr., Adams, C.S., Hickok, N.J., Shapiro, I.M., and Parvizi, J. Vancomycin bound to Ti rods reduces peripros-thetic infection: preliminary study. Clin Orthop Relat Res 461, 88, 2007.
23. Peersman, G., Laskin, R., Davis, J., and Peterson, M. Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res 392, 15, 2001.
24. Loll, P.J., and Axelsen, P.H. The structural biology of molecular recognition by vancomycin. Ann Rev Biophys Biomol Struc 29, 265, 2000.
25. Anderson, H. Molecular biology of matrix vesicles. Clin Orthop Relat Res 314, 266, 1995.
26. Landis, W., and Silver, F. Mineral deposition in the extracellular matrices of vertebrate tissues: identification of possible apatite nucleation sites on type I collagen. Cells Tissues Organs 189, 20, 2009.
27. Fux, C., Costerton, J., Stewart, P., and Stoodley, P. Survival strategies of infectious biofilms. Trends Microbiol 13, 34, 2005.
28. Schopka, S., Schmid, F., Hirt, S., Birnbaum, D., Schmid, C., and Lehle, K. Recellularization of biological heart valves with human vascular cells: in vitro hemocompatibility assessment. J Biomed Mater Res Part B Appl Biomater 88, 130, 2009.
29. Rieder, E. Tissue engineering of heart valves: decellularized porcine and human valve scaffolds differ importantly in residual potential to attract monocytic cells. Circulation 111, 2792, 2005.
30. Ott, H., Matthiesen, T., Goh, S., Black, L., Kren, S., Netoff, T., and Taylor, D. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14, 213, 2008.
31. Ye, X., Zhao, Q., Sun, X., and Li, H. Enhancement of mes-enchymal stem cell attachment to decellularized porcine aortic valve scaffold by in vitro coating with antibody against CD90: a preliminary study on antibody-modified tissue-engineered heart valve. Tissue Eng A 15, 1, 2008.